On March 3, it was reported that, Hemispherx Biopharma, Inc. (NYSEMKT:HEB) has installed a 600 litre bioreactor at its manufacturing facility in New Jersey and plans to seek approval to restart production of its alpha interferon product, Alferon N Injection. On Thursday shares of Hemispherx Biopharma, Inc. (NYSEMKT:HEB) closed at $0.26. Company’s sales growth for last 5 years was -7.80% and EPS growth for next 5 years is recorded as 25.00%.
On February 24, Dyax Corp (NASDAQ:DYAX) reported Q4 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $26 million versus the consensus estimate of $19.9 million. Dyax Corp. (NASDAQ:DYAX) in last trading activity increased 0.13% to close at $15.69. Company weekly performance is 1.36% while its quarterly performance stands at 10.57%. Dyax Corp. (NASDAQ:DYAX) is -8.78% away from its 52 week high.
Rentrak (NASDAQ: RENT) announced the top weekly cross-platform entertainment rankings for March 4, 2015. Universal’s “Fifty Shades of Grey” remains a staggering worldwide phenomenon with $486.2 million to-date after adding nearly $50 million in 60 territories as it tops the global chart again this weekend. The modestly budgeted erotic drama will cross the $500 million mark globally this week making it one of the most profitable films released over the past year. On last trading day Rentrak Corporation (NASDAQ:RENT) decreased -1.40% to close at $56.52. Its volatility for the week is 3.67% while volatility for the month is 6.26%. RENT’s sales growth for past 5 years was -4.50% and its EPS growth for past 5 years was -26.10%. Rentrak Corporation (NASDAQ:RENT) monthly performance is -28.16%.
Newfield Exploration Co. (NYSE:NFX) has priced its public offering of $700 million of 5⅜% senior notes due 2026, an increase over the previously announced offering of $500 million aggregate principal amount. The notes were issued at par. The company expects to close the offering on March 10, and intends to use the net proceeds from the offering, along with cash on hand or borrowings under its revolving credit facility, to redeem its outstanding 6⅞% senior subordinated notes due 2020. Newfield Exploration Co. (NYSE:NFX) has 0.30% insider ownership while its institutional ownership stands at 96.50%. In last trading activity company’s stock closed at $32.77.
Canaccord Genuity restated their buy rating on shares ofSynageva Biopharma Corp (NASDAQ:GEVA) in a report issued on Friday. They currently have a $125.00 target price on the stock. On last trading day Synageva BioPharma Corp. (NASDAQ:GEVA) decreased -1.03% to close at $101.24. Its volatility for the week is 6.62% while volatility for the month is 5.41%. GEVA’s sales growth for past 5 years was -7.30% and its EPS growth for past 5 years was -31.20%. Synageva BioPharma Corp. (NASDAQ:GEVA) monthly performance is -3.76%.